| 000 | 05747cam a2200469Mi 4500 | ||
|---|---|---|---|
| 999 |
_c95292 _d95292 |
||
| 001 | 95292 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112656.0 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 170130s2017 sz o 000 0 eng d | ||
| 020 |
_a3319505203 _q(electronic bk.) |
||
| 020 |
_a9783319505206 _q(electronic bk.) |
||
| 020 |
_z331950519X _q(print) |
||
| 020 |
_z9783319505190 _q(print) |
||
| 035 |
_a(OCoLC)970781788 _z(OCoLC)970393477 _z(OCoLC)971031210 _z(OCoLC)971091439 _z(OCoLC)971230449 _z(OCoLC)971357114 _z(OCoLC)971365118 _z(OCoLC)971521501 _z(OCoLC)974650098 _z(OCoLC)981775813 _z(OCoLC)994454567 _z(OCoLC)1004761954 _z(OCoLC)1005787728 _z(OCoLC)1011849659 |
||
| 040 |
_aYDX _cYDX _dN$T _dGW5XE _dIDEBK _dCOO _dOCLCQ _dNJR _dN$T _dEBLCP _dUPM _dUAB _dOCLCO _dMERUC _dIOG _dOCLCO _dESU _dOCLCO _dMERER _dOCLCO _dJBG _dIAD _dOCLCO _dICW _dOCLCO _dICN _dOCLCQ _dOCLCO _dOTZ _dOCLCO _dOCLCQ _dVT2 _dOCLCQ _dOCLCO _dOCLCQ _dJG0 _dOCLCO _dU3W _dOCLCO _dOCLCQ _dES-MaUEC _bspa |
||
| 050 | 4 |
_aQR201.H44 _bM654 2017 EB |
|
| 245 | 0 | 0 |
_aMolecular pathogenesis and signal transduction by helicobacter pylori _cNicole Tegtmeyer, Steffen Backert, editors. |
| 264 | 1 |
_aCham, Switzerland _bSpringer _c2017 |
|
| 300 | _a1 recurso en línea | ||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 0 |
_aCurrent topics in microbiology and immunology _vvolume 400 |
|
| 500 | _aSpringerLink | ||
| 505 | 0 | _aForeword; Preface; Contents; Abbreviations; 1 The Human Stomach in Health and Disease: Infection Strategies by Helicobacter pylori; Abstract; 1 Introduction; 2 H. pylori Infection and Strategies of Persistence; 3 H. pylori Infection in Health and Disease; 3.1 Gastritis; 3.2 Peptic Ulcer Disease; 3.3 Gastric Adenocarcinoma; 3.4 MALT Lymphoma; 4 H. pylori Virulence Factors and their Association with Disease; 4.1 The cag Pathogenicity Island; 4.2 Vacuolating Cytotoxin (VacA); 4.3 DupA and tfs4; 4.4 NapA; 4.5 Adhesins; 5 Environmental Factors and their Association with Disease. | |
| 505 | 8 | _a2.3 Inhibition of Antimicrobial Peptides3 Immune Tolerance Driven by H. pylori Interaction with Dendritic Cells; 4 Manipulation and Inhibition of Effector T Cell Responses; 5 Bacterial Plasticity and Immune Evasion; 6 Concluding Remarks; References; 4 Recent Advances in Helicobacter pylori Replication: Possible Implications in Adaptation to a Pathogenic Lifestyle and Perspectives for Drug Design; Abstract; 1 Introduction; 2 Chromosome Replication in Bacteria; 3 Chromosome Replication in Helicobacter pylori; 3.1 Initiation; 3.2 Elongation; 3.3 Termination; 3.4 Segregation. | |
| 505 | 8 | _a4 Regulation of H. pylori Chromosome Replication5 Plasmid Replication in Bacteria; 6 Plasmid Replication in Helicobacter pylori; 7 Beyond the Replication Flowchart; 8 Concluding Remarks; Acknowledgements; References; 5 The Helicobacter pylori Methylome: Roles in Gene Regulation and Virulence; Abstract; 1 Introduction; 2 The Restriction-Modification (R-M) Systems and Their Diversity in H. pylori; 3 The H. pylori Methylomes; 4 Roles of H. pylori Methyltransferases (Mtases) in Gene Regulation; 4.1 Gene Regulation by E. coli Deoxyadenosine Methyltransferase (Dam) and Its Homologues. | |
| 505 | 8 | _a4.2 NO-Mediated H. pylori Carcinogenesis4.3 NOS2 Polymorphisms; 5 The Host and Bacteria Coevolution: The Crystal Ball of H. pylori Pathogenesis?; 6 Concluding Remarks; References; 3 Immune Evasion Strategies and Persistence of Helicobacter pylori; Abstract; 1 Introduction; 2 Innate Immune Evasion Strategies of H. pylori; 2.1 Evasion and Manipulation of Pattern Recognition Receptors; 2.1.1 Evasion of TLR Recognition and Manipulation of TLR-Mediated Signaling; 2.1.2 Inhibition of CLR-Mediated Signaling; 2.2 Inhibition of Phagocytosis and Killing by Reactive Oxygen Species and Nitric Oxide. | |
| 505 | 8 | _a6 Treatment of H. pylori and Prospects for a Vaccine7 Concluding Remarks; Acknowledgements; References; 2 Human and Helicobacter pylori Interactions Determine the Outcome of Gastric Diseases; Abstract; 1 Helicobacter pylori: From Infection to Diseases; 2 The Chemokine CXCL8; 2.1 Induction of CXCL8 by H. pylori; 2.2 CXCL8 Gene Polymorphisms; 3 Induction and Role of ROS; 3.1 ROS During H. pylori Infection; 3.2 Expression and Role of NOX1; 3.3 Expression and Role of NOX2; 3.4 Expression and Role of SMOX; 3.5 Epigenetic Regulation of SMOX; 4 Nitrosative Stress; 4.1 H. pylori Infection and NOS2. | |
| 520 | 3 | _aThis volume reviews the current state of research concerning bacterial virulence factors and the infection biology of Helicobacter pylori, which is the leading cause of peptic ulcers and gastric cancer worldwide. The chapters include cutting-edge findings on this fascinating microbe and discuss the general strategies of H. pylori infection and persistence, news on important H. pylori virulence factors, crosstalk with the microbiota, hot novel models and signaling mechanisms, risk factors of gastric disease and stomach cancer, and the impact of H. pylori infection on non-gastric diseases. Written by internationally respected scientists, this book will appeal to clinicians, researchers and advanced students alike. | |
| 588 | 0 | _aVersión impresa | |
| 988 | _aEBOOK, EBSPRINGER_2017B | ||
| 650 | 7 |
_2embne _9150368 _aInfecciones por Helicobacter pylori |
|
| 700 | 1 |
_aBackert, Steffen, _eeditor literario _999785 |
|
| 700 | 1 |
_aTegtmeyer, Nicole, _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-50520-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b02/2018 _dz _e- _zSI |
||